Aquestive therapeutics announces common stock purchase agreement for up to $40 million with lincoln park capital

Warren, n.j., april 13, 2022 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst), a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, today announced it has entered into a common stock purchase agreement for up to $40 million with lincoln park capital fund, llc (“lpc”), a chicago-based institutional investor.
AQST Ratings Summary
AQST Quant Ranking